{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:53:23Z","timestamp":1770220403716,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12282-018-0906-0","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T08:31:45Z","timestamp":1537259505000},"page":"244-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinico-radiologic features and management of hematological tumors in the breast: a case series"],"prefix":"10.1007","volume":"26","author":[{"given":"Joseph T.","family":"Hoang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeeshan A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Spigel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Pippen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"906_CR1","volume-title":"Global cancer facts & figs","author":"American Cancer Society","year":"2015","unstructured":"American Cancer Society. Global cancer facts & figs. 3rd\u00a0ed. Atlanta: American Cancer Society; 2015."},{"key":"906_CR2","first-page":"47","volume":"85","author":"P Galieni","year":"2000","unstructured":"Galieni P, Cavo M, Pulsoni A, Avvisati G, Bigazzi C, Neri S, et al. Clinical outcome of extramedullary plasmacytoma. Haematologica. 2000;85:47\u201351.","journal-title":"Haematologica"},{"key":"906_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/08998280.2017.11929587","volume":"30","author":"DK Le","year":"2017","unstructured":"Le DK, Metter D, Krause JR. Plasmablastic plasmacytoma of the breast. Proc (Bayl Univ Med Cent). 2017;30:203\u20134.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"906_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijscr.2016.05.041","volume":"25","author":"SB Koganti","year":"2016","unstructured":"Koganti SB, Lozada A, Curras E, Shah A. Marginal zone lymphoma of the breast\u2014a diminished role for surgery. Int J Surg Case Rep. 2016;25:4\u20136.","journal-title":"Int J Surg Case Rep"},{"key":"906_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1023\/A:1008313229892","volume":"10","author":"E Zucca","year":"1999","unstructured":"Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin\u2019s lymphomas. Part 2: head and neck, central nervous system and other less common sites. Ann Oncol. 1999;10:1023\u201333.","journal-title":"Ann Oncol"},{"key":"906_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000345474","volume":"7","author":"BE Bilir","year":"2012","unstructured":"Bilir BE, Atile NS, Bilir B, Guldiken S, Tuncbilek N, Puyan FO, et al. A metabolic syndrome case presenting with lymphocytic mastitis. Breast Care (Basel). 2012;7:493\u20135.","journal-title":"Breast Care (Basel)"},{"key":"906_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/PAT.0000000000000187","volume":"47","author":"A Chougule","year":"2015","unstructured":"Chougule A, Bal A, Das A, Singh G. IgG4 related sclerosing mastitis: expanding the morphological spectrum of IgG4 related diseases. Pathology. 2015;47:27\u201333.","journal-title":"Pathology"},{"key":"906_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/01.dad.0000179463.55129.8a","volume":"27","author":"L Boudova","year":"2005","unstructured":"Boudova L, Kazakov DV, Sima R, Vanecek T, Torlakovic E, Lamovec J, et al. Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients. Am J Dermatopathol. 2005;27:375\u201386.","journal-title":"Am J Dermatopathol"},{"key":"906_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0720-048X(01)00416-8","volume":"42","author":"FB Demirkazik","year":"2002","unstructured":"Demirkazik FB. MR imaging features of breast lymphoma. Eur J Radiol. 2002;42:62\u20134.","journal-title":"Eur J Radiol"},{"key":"906_CR10","first-page":"1","volume":"1","author":"G Gloustianou","year":"2016","unstructured":"Gloustianou G, Lakiotaki E, Riccioni O, Lazaris AC. Primary manifestation of marginal zone lymphoma in the breast. Clin Oncol. 2016;1:1\u20133.","journal-title":"Clin Oncol"},{"key":"906_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/annonc\/mdp238","volume":"20","author":"G Martinelli","year":"2009","unstructured":"Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, et al. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2009;20:1993\u20139.","journal-title":"Ann Oncol"},{"key":"906_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ajh.24052","volume":"90","author":"JJ Castillo","year":"2015","unstructured":"Castillo JJ, Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP. Survival outcomes of secondary cancers in patients with Waldenstrom macroglobulinemia: an analysis of the SEER database. Am J Hematol. 2015;90:696\u2013701.","journal-title":"Am J Hematol"},{"key":"906_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/modpathol.2014.120","volume":"28","author":"F Hamadeh","year":"2015","unstructured":"Hamadeh F, MacNamara SP, Aguilera NS, Swerdlow SH, Cook JR. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma. Mod Pathol. 2015;28:564\u201374.","journal-title":"Mod Pathol"},{"key":"906_CR14","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1259\/bjr\/78413721","volume":"85","author":"A Surov","year":"2012","unstructured":"Surov A, Holzhausen HJ, Wienke A, Schmidt J, Thomssen C, Arnold D, et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. Br J Radiol. 2012;85:e195\u2013205.","journal-title":"Br J Radiol"},{"key":"906_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1259\/bjr.72.853.10341695","volume":"72","author":"PM Lamb","year":"1999","unstructured":"Lamb PM, Perry NM, Mulele CK. Waldenstrom\u2019s macroglobulinaemia of the breast detected by colour Doppler ultrasound. Br J Radiol. 1999;72:82\u20134.","journal-title":"Br J Radiol"},{"key":"906_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1634\/theoncologist.5-1-63","volume":"5","author":"MA Gertz","year":"2000","unstructured":"Gertz MA, Fonseca R, Rajkumar SV. Waldenstrom\u2019s macroglobulinemia. Oncologist. 2000;5:63\u20137.","journal-title":"Oncologist"},{"key":"906_CR17","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2018","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H.\u00a0WHO classification of tumours of haematopoietic and lymphoid tissues. Fourth edition.\u00a0Lyon, France: IARC; 2018."},{"key":"906_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4065\/mcp.2010.0304","volume":"85","author":"SM Ansell","year":"2010","unstructured":"Ansell SM, Kyle RA, Reeder CB, Fonseca R, Mikhael JR, Morice WG, et al. Diagnosis and management of Waldenstrom macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc. 2010;85:824\u201333.","journal-title":"Mayo Clin Proc"},{"key":"906_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.5858\/arpa.2012-0034-RS","volume":"137","author":"N Naderi","year":"2013","unstructured":"Naderi N, Yang DT. Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia. Arch Pathol Lab Med. 2013;137:580\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"906_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(61)91420-9","volume":"1","author":"J Innes","year":"1961","unstructured":"Innes J, Newall J, Myelomatosis. Lancet. 1961;1:239\u201345.","journal-title":"Lancet"},{"key":"906_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/02841851003712924","volume":"51","author":"A Surov","year":"2010","unstructured":"Surov A, Holzhausen HJ, Ruschke K, Arnold D, Spielmann RP. Breast plasmacytoma. Acta Radiol. 2010;51:498\u2013504.","journal-title":"Acta Radiol"},{"key":"906_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/modpathol.3800355","volume":"18","author":"F Vega","year":"2005","unstructured":"Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005;18:806\u201315.","journal-title":"Mod Pathol"},{"key":"906_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.beha.2010.09.002","volume":"23","author":"S Kumar","year":"2010","unstructured":"Kumar S, Kimlinger T, Morice W. Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol. 2010;23:433\u201351.","journal-title":"Best Pract Res Clin Haematol"},{"key":"906_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.6004\/jnccn.2017.0023","volume":"15","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Chandler JC, et al. Multiple myeloma, version 3.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15:230\u201369.","journal-title":"J Natl Compr Canc Netw"},{"key":"906_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","volume":"17","author":"N Thumallapally","year":"2017","unstructured":"Thumallapally N, Meshref A, Mousa M, Terjanian T. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer. 2017;17:13.","journal-title":"BMC Cancer"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-018-0906-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-018-0906-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-018-0906-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:32:46Z","timestamp":1568763166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-018-0906-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s12282-018-0906-0","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"assertion":[{"value":"11 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have any potential conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}